Responses
Poster Presentations
Category: Clinical case reports
P41 Stribild™ (Emtricitabine/Tenofovir/Elvitegravir/Cobicistat) and darunavir: a novel regimen for the pi experienced, ritonavir intolerant patient
Compose a Response to This Article
Other responses
No responses have been published for this article.